Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation

Raven, Lisa M. and Muir, Christopher A. and Deveza, Ricardo C. and Kessler Iglesias, Cassia and Bart, Nicole K. and Muthiah, Kavitha and Kotlyar, Eugene and Hayward, Christopher S. and Macdonald, Peter S. and Jabbour, Andrew and Greenfield, Jerry R. (2024) Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation. JHLT Open, 5. p. 100088. ISSN 29501334

Full text not available from this repository.
Link to published document: https://doi.org/10.1016/j.jhlto.2024.100088

Abstract

Sodium glucose cotransporter 2 inhibitors (SGLT2i) are an established treatment for heart failure and type 2 diabetes. Guidelines suggest withholding SGLT2i preoperatively due to the risk of ketoacidosis. Orthotopic heart transplantation (OHT) occurs without sufficient notice to cease SGLT2i treatment before surgery. In a retrospective analysis of 163 OHT recipients (40 exposed to SGLT2i, 123 not exposed), we show no increase in rates of mild, moderate, or severe acidosis postoperatively. No cases of ketoacidosis occurred, likely due to the fact that 97% of patients received insulin infusions postoperatively for transient postoperative hyperglycemia. Patients exposed to SGLT2i had shorter length of stay in the intensive care unit and improved adjusted survival overall. These findings support the safety of SGLT2i use up to the time of OHT with routine use of a postoperative insulin infusion.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 05 May 2025 00:26
Last Modified: 05 May 2025 00:26
URI: https://eprints.victorchang.edu.au/id/eprint/1650

Actions (login required)

View Item View Item